A Long-term Trial of EB-1020 in Adult Patients With ADHD

Clinical trial NCT06926829 · RECRUITING

Trial details

NCT number: NCT06926829
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2025-06-25
Primary completion: 2027-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.